Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.
The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.
The global Internal Neuromodulation market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Internal Neuromodulation volume and value at global level, regional level and company level. From a global perspective, this report represents overall Internal Neuromodulation market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Medtronic PLC
St. Jude Medical
Boston Scientific Corp.
Cerbomed GMBH
Cyberonics
Biocontrol Medical
Depuy Synthes Companies
Enteromedics
Synapse Biomedical
Uroplasty
Greatbatch
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Neuro Stimulator
Segment by Application
Parkinsons Disease
Chronic Pain
Others
Table of Contents
Executive Summary
1 Internal Neuromodulation Market Overview
1.1 Product Overview and Scope of Internal Neuromodulation
1.2 Internal Neuromodulation Segment by Type
1.2.1 Global Internal Neuromodulation Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Spinal Cord Stimulator
1.2.3 Deep Brain Stimulator
1.2.4 Sacral Nerve Stimulator
1.2.5 Vagus Nerve Stimulator
1.2.6 Gastric Neuro Stimulator
1.3 Internal Neuromodulation Segment by Application
1.3.1 Internal Neuromodulation Consumption Comparison by Application (2014-2025)
1.3.2 Parkinsons Disease
1.3.3 Chronic Pain
1.3.4 Others
1.4 Global Internal Neuromodulation Market by Region
1.4.1 Global Internal Neuromodulation Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Internal Neuromodulation Market Size
1.5.1 Global Internal Neuromodulation Revenue (2014-2025)
1.5.2 Global Internal Neuromodulation Production (2014-2025)
2 Global Internal Neuromodulation Market Competition by Manufacturers
2.1 Global Internal Neuromodulation Production Market Share by Manufacturers (2014-2019)
2.2 Global Internal Neuromodulation Revenue Share by Manufacturers (2014-2019)
2.3 Global Internal Neuromodulation Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Internal Neuromodulation Production Sites, Area Served, Product Types
2.5 Internal Neuromodulation Market Competitive Situation and Trends
Summary: Get latest Market Research Reports on Internal Neuromodulation . Industry analysis & Market Report on Internal Neuromodulation is a syndicated market report, published as Global Internal Neuromodulation Market Research Report 2019. It is complete Research Study and Industry Analysis of Internal Neuromodulation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.